Neurocritical Care

, Volume 13, Issue 3, pp 331–338 | Cite as

Continuous Cardiac Output and Near-Infrared Spectroscopy Monitoring to Assist in Management of Symptomatic Cerebral Vasospasm After Subarachnoid Hemorrhage

  • Tatsushi MutohEmail author
  • Tatsuya Ishikawa
  • Akifumi Suzuki
  • Nobuyuki Yasui
Original Article



Hemodynamic augmentation by increasing cardiac output with dobutamine (DOB) is believed to be a useful method of elevating decreased cerebral blood flow in the territory affected by vasospasm following aneurysmal subarachnoid hemorrhage (SAH). We described the clinical utility of uncalibrated radial artery-based pulse contour cardiac output (APCO) and near-infrared spectroscopy regional cerebral oxygen saturation (rSO2) monitoring for reversing vasospasm symptoms with DOB-induced hyperdynamic therapy.


Seven consecutive patients who underwent surgical clipping within 24 h of SAH onset and subsequently developed delayed ischemic neurological deficits attributable to vasospasm were investigated. They were treated with DOB administered at a dose of 3 μg/kg/min and then increased in 3 μg/kg/min increments until resolution of the symptoms. Continuous APCO and rSO2 measurements in conjunction with the assessment of clinical courses and outcomes were performed.


In spasm-affected territories, decreased and/or fluctuating rSO2 was detected at baseline compared with recordings in other brain regions. Patients who exhibited rapid elevation of APCO in response to an incremental dose of DOB had subsequent uptake and stabilization of rSO2 followed by improvement of vasospasm-related clinical symptoms with a maximal dose of DOB, resulted in favorable functional outcomes thereafter. A fairly strong relationship was found between peak APCO slope and rSO2 elevation, with a significantly high area under the receiver operating characteristic curve predicting neurological improvement with DOB treatment.


Our clinical experience indicates that integrative monitoring with APCO and rSO2 may provide continuous, real-time, and clinically relevant information on the effectiveness of medical treatment of distal vessel vasospasm.


Cardiac output Cerebral oximetry Hemodynamic augmentation Near-infrared spectroscopy Subarachnoid hemorrhage Vasospasm 



This work was supported by an institutional research Grant (H221001) from Akita Prefecture.


  1. 1.
    van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306–18.CrossRefPubMedGoogle Scholar
  2. 2.
    Sen J, Belli A, Albon H, et al. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2(10):614–21.CrossRefPubMedGoogle Scholar
  3. 3.
    Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354(4):387–96.CrossRefPubMedGoogle Scholar
  4. 4.
    Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, american heart association. Stroke. 2009;40(3):994–1025.CrossRefPubMedGoogle Scholar
  5. 5.
    Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35(8):1844–51.CrossRefPubMedGoogle Scholar
  6. 6.
    Hadeishi H, Mizuno M, Suzuki A, Yasui N. Hyperdynamic therapy for cerebral vasospasm. Neurol Med Chir (Tokyo). 1990;30(5):317–23.CrossRefGoogle Scholar
  7. 7.
    Joseph M, Ziadi S, Nates J, et al. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery. 2003;53(5):1044–51. discussion 1051–42.PubMedGoogle Scholar
  8. 8.
    Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg. 1993;79(4):494–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Mutoh T, Ishikawa T, Nakase T, et al. Impact of early goal-directed hemodynamic optimization on clinical management and outcome after subarachnoid hemorrhage: a prospective controlled study. Neurology. 2010;74(9 suppl 2):130.Google Scholar
  10. 10.
    Scheeren TW, Wiesenack C, Compton FD, et al. Performance of a minimally invasive cardiac output monitoring system (FloTrac/Vigileo). Br J Anaesth. 2008;101(2):279–80.CrossRefPubMedGoogle Scholar
  11. 11.
    Oddo M, Milby A, Chen I, et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2009;40(4):1275–81.CrossRefPubMedGoogle Scholar
  12. 12.
    Zada G, Terterov S, Russin J, et al. Cerebral vasospasm and concurrent left ventricular outflow tract obstruction: requirement for modification of hyperdynamic therapy regimen. Neurocrit Care. 2009;12(2):265–8.CrossRefGoogle Scholar
  13. 13.
    Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20(3):188–92.CrossRefPubMedGoogle Scholar
  14. 14.
    Mutoh T, Kazumata K, Ajiki M, et al. Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage. Stroke. 2007;38(12):3218–24.CrossRefPubMedGoogle Scholar
  15. 15.
    Naidech A, Du Y, Kreiter KT, et al. Dobutamine versus milrinone after subarachnoid hemorrhage. Neurosurgery. 2005;56(1):21–7.PubMedGoogle Scholar
  16. 16.
    Yoshitani K, Kawaguchi M, Miura N, et al. Effects of hemoglobin concentration, skull thickness, and the area of the cerebrospinal fluid layer on near-infrared spectroscopy measurements. Anesthesiology. 2007;106(3):458–62.CrossRefPubMedGoogle Scholar
  17. 17.
    Kishi K, Kawaguchi M, Yoshitani K, et al. Influence of patient variables and sensor location on regional cerebral oxygen saturation measured by INVOS 4100 near-infrared spectrophotometers. J Neurosurg Anesthesiol. 2003;15(4):302–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Calderon-Arnulphi M, Alaraj A, Slavin KV. Near infrared technology in neuroscience: past, present and future. Neurol Res. 2009;31(6):605–14.CrossRefPubMedGoogle Scholar
  19. 19.
    Mutoh T, Kazumata K, Ishikawa T, Terasaka S. Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage. Stroke. 2009;40(7):2368–74.CrossRefPubMedGoogle Scholar
  20. 20.
    Mutoh T, Ishikawa T, Yasui N. Application of the FloTrac arterial pressure-based continuous cardiac output monitor to dobutamine-induced hyperdynamic therapy for cerebral vasospasm after subarachnoid hemorrhage. No Shinkei Geka. 2009;37(11):1085–93.PubMedGoogle Scholar
  21. 21.
    Mutoh T, Ishikawa T, Nishino K, Yasui N. Evaluation of the FloTrac uncalibrated continuous cardiac output system for perioperative hemodynamic monitoring after subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2009;21(3):218–25.CrossRefPubMedGoogle Scholar
  22. 22.
    Aaslid R. Development and principles of transcranial Doppler. In: Newell DW, Asalid R, editors. Transcranial Doppler. New York, NY: Raven Press; 1992. p. 1–8.Google Scholar
  23. 23.
    Lindegaard KF, Nornes H, Bakke SJ, et al. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien). 1989;100(1–2):12–24.CrossRefGoogle Scholar
  24. 24.
    Edwards Lifesciences. FloTrac system 3rd generation software. Accessed 6 April 2009.
  25. 25.
    Suarez JI, Qureshi AI, Yahia AB, et al. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med. 2002;30(6):1348–55.CrossRefPubMedGoogle Scholar
  26. 26.
    Lysakowski C, Walder B, Costanza MC, Tramer MR. Transcranial doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke. 2001;32(10):2292–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke. 2009;40(6):1963–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Naidech AM, Bendok BR, Ault ML, Bleck TP. Monitoring with the somanetics invos 5100c after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2008;9(3):326–31.CrossRefPubMedGoogle Scholar
  29. 29.
    Ekelund A, Kongstad P, Saveland H, et al. Transcranial cerebral oximetry related to transcranial doppler after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 1998;140(10):1029–35 (discussion 1035–26).CrossRefGoogle Scholar
  30. 30.
    Rothoerl RD, Faltermeier R, Burger R, et al. Dynamic correlation between tissue po2 and near infrared spectroscopy. Acta Neurochir Suppl. 2002;81:311–3.PubMedGoogle Scholar
  31. 31.
    Luer MS, Dujovny M, Slavin KV, et al. Regional cerebral oxygen saturation during intra-arterial papaverine therapy for vasospasm: case report. Neurosurgery. 1995;36(5):1033–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Tatsushi Mutoh
    • 1
    Email author
  • Tatsuya Ishikawa
    • 1
  • Akifumi Suzuki
    • 1
  • Nobuyuki Yasui
    • 1
  1. 1.Department of Surgical NeurologyResearch Institute for Brain and Blood Vessels-AkitaAkitaJapan

Personalised recommendations